Browsing by Ajou Author

강, 석윤(Kang, Seok Yun) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Hematology-Oncology]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 21 to 40 of 104

This table browses all dspace content
Pub YearTitleAuthor(s)
2020Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)강석윤
2020Combination versus single-agent as palliative chemotherapy for gastric cancer강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁
2020Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial강석윤
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤, 안미선, 이현우
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
2019EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment강석윤
2019Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?강석윤, 안미선, 이현우, 최용원, 최진혁
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤
2019A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)강석윤
2019Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)강석윤
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression강석윤, 김장희, 박태준, 최용원
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial강석윤
2019The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study강석윤
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2018Should combination chemotherapy be used in all advanced gastric cancer patients?강석윤, 안미선, 이현우, 최용원, 최진혁
2018Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy강석윤, 안미선, 이현우, 최용원, 최진혁
2018469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁
2018EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호
2018Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy강석윤
2018Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
1 2 3 4 5 6

Browse